nomacopan (rVA576)
AK901
Phase 3 small_molecule terminated
Quick answer
nomacopan (rVA576) for Thrombotic Microangiopathies is a Phase 3 program (small_molecule) at Akari Therapeutics Plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akari Therapeutics Plc
- Indication
- Thrombotic Microangiopathies
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated